Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003486493 | SCV004241177 | pathogenic | Developmental and epileptic encephalopathy, 1 | 2023-12-15 | criteria provided, single submitter | clinical testing | Variant summary: ARX c.451_464del14 (p.Ala151LeufsX82) results in a premature termination codon, predicted to cause absence of the protein due to nonsense mediated decay, which is a commonly known mechanism for disease. The variant was absent in 14421 control chromosomes. To our knowledge, no occurrence of c.451_464del14 in individuals affected with Developmental and epileptic encephalopathy and no experimental evidence demonstrating its impact on protein function have been reported. No submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic. |